Skip to main content
Fig. 2 | BMC Medical Research Methodology

Fig. 2

From: Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection

Fig. 2

Smoothed hazard plots from Part A of the JAVELIN Merkel 200 clinical trial. Note: Owing to the sample size of JAVELIN Merkel 200 Part A (n = 88 patients), the max.time argument required by the muhaz function was set to the minimum follow-up time for each data cut. Consequently, the smoothed hazard estimate for each data cut is presented within this figure for a limited time period

Back to article page

BMC Medical Research Methodology

ISSN: 1471-2288

Contact us